Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Study Shows BSGI/MBI Contributes Significantly to Patient Management with Its Ability to Detect Breast Cancer in Difficult to Diagnose Patients

December 14, 2010 By Bio-Medicine.Org

PITTSBURGH, Dec. 14, 2010 /PRNewswire/ — Dr. Barbara Ward and
others of Weinstein Imaging determined that Breast-Specific Gamma
Imaging/Molecular Breast Imaging (BSGI/MBI) provides additional
information when conventional imaging is indeterminate and greater
confidence is required to improve diagnostic accuracy.  The
data from the retrospective study demonstrated that BSGI
contributed significantly to patient management by detecting cancer
in 7 of the 73 patients (9%), and was presented last week at the
San Antonio Breast Cancer Symposium.

BSGI/MBI is a molecular breast imaging technique that is used to
identify early stage cancers by means of a high-resolution, small
field-of-view gamma camera and a radiotracer. Cells with increased
metabolic activity, such as rapidly dividing cancers,
preferentially absorb this tracer and are viewed as dark spots on
the BSGI image. BSGI is a diagnostic complement to mammography, and
is especially helpful for patients with negative or indeterminate
mammograms and an unresolved clinical concern such as indeterminate
densities, new vague calcifications, bloody nipple discharge, focal
breast pain or palpable masses; especially in those of elevated
risk and patients with dense breast tissue.

The study included 73 patients with 79 regions of concern that
were classified as indeterminate following mammography and
ultrasound.  There were 7 biopsy proven malignant lesions and
72 benign findings on pathology or follow-up imaging.  BSGI
was positive in 7 malignant and 21 benign lesions and negative in
51 benign lesions, yielding a sensitivity of 100% and specificity
of 71%.  The study showed that BSGI/MBI is a useful
complimentary tool in the diagnostic work up of patients when a
diagnostic concern remains after negative or indeterminate
conventional imaging.

About Dilon Diagnostics

Dilon Diagnostics, a brand of Dilon Technologies Inc., is
bringing innovative medical imaging

‘/>”/>

SOURCE

Related Articles Read More >

A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
Biotronik
FDA approves Biotronik’s programmer for implanted cardiac rhythm management devices

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech